Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

Pfizer doses first patient in investigational haemophilia drug trial

Pfizer doses first patient in investigational haemophilia drug trial A number of treatments on the market are designed to replace factor VII, including both short-acting and newer long-acting versions such as Shire’s Adynovate, Biogen’s Eloctate,

Bayer's drop of the future

Bayer's drop of the future Her remark was engendered by my inordinate excitement over a news announcement that Bayer has extended its agreement with One Drop, the digital health company. ... And in Bayer/One Drop we see a holobiont business model designed to bring together

Bayer pays an initial $2bn for gene therapy firm AskBio

Bayer pays an initial $2bn for gene therapy firm AskBio Acquisition will expand Bayers’s pipeline with preclinical/clinical candidates. Bayer has announced its acquisition of Asklepios BioPharmaceutical (AskBio) to bolster its presence in cell and gene therapy, paying up to ... CDMO). On top of the upfront

Finalists

Switch 4 Them” - Protecting Vulnerable Patients During a Pandemic. by Bayer.

Amgen, Cytokinetics’ heart failure drug disappoints in phase 3

Amgen, Cytokinetics’ heart failure drug disappoints in phase 3 Also coming through the pipeline is Merck &Co and Bayer’s high-risk heart failure drug vericiguat which is currently being studied in patients with worsening chronic heart failure with reduced

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mind+Matter

We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...